Detalhe da pesquisa
1.
A Financial and Global Demand Analysis to Inform Decisions for Funding and Clinical Development of Group B Streptococcus Vaccines for Pregnant Women.
Clin Infect Dis
; 74(Suppl_1): S70-S79, 2022 01 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-34725684
2.
Stakeholder Perceptions About Group B Streptococcus Disease and Potential for Maternal Vaccination in Low- and Middle-Income Countries.
Clin Infect Dis
; 74(Suppl_1): S80-S87, 2022 01 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-34558611
3.
A review of potential use cases for measles-rubella, measles-mumps-rubella, and typhoid-conjugate vaccines presented on microarray patches.
Vaccine
; 42(6): 1230-1246, 2024 Feb 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-38326130
4.
Vaccine value profile for leishmaniasis.
Vaccine
; 41 Suppl 2: S153-S175, 2023 11 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-37951693
5.
Impact and cost-effectiveness of measles vaccination through microarray patches in 70 low-income and middle-income countries: mathematical modelling and early-stage economic evaluation.
BMJ Glob Health
; 8(11)2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37949503
6.
Exploring potential applications of measles and rubella microarray patches (MR-MAPs): use case identification.
Front Public Health
; 11: 1165110, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37377552
7.
The Global Demand and Supply Balance of the Human Papillomavirus Vaccine: Implications for the Global Strategy for the Elimination of Cervical Cancer.
Vaccines (Basel)
; 12(1)2023 Dec 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-38276663
8.
Estimating the global demand curve for a leishmaniasis vaccine: A generalisable approach based on global burden of disease estimates.
PLoS Negl Trop Dis
; 16(6): e0010471, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35696433
9.
The quest for more effective vaccine markets - Opportunities, challenges, and what has changed with the SARS-CoV-2 pandemic.
Vaccine
; 2022 Oct 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38103962
10.
Improving access to human papillomavirus vaccines: A case study in the IA2030 core principle of partnership.
Vaccine
; 2022 Dec 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36496285
11.
Estimating the future global dose demand for measles-rubella microarray patches.
Front Public Health
; 10: 1037157, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36726626
12.
COVID-19 impact on infant and adolescent vaccine supplies.
Science
; 374(6574): 1438-1441, 2021 Dec 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-34914520
13.
Human leishmaniasis vaccines: Use cases, target population and potential global demand.
PLoS Negl Trop Dis
; 15(9): e0009742, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34547025
14.
Overcoming roadblocks in the development of vaccines for leishmaniasis.
Expert Rev Vaccines
; 20(11): 1419-1430, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-34727814
15.
Global Vaccine Action Plan lessons learned III: Monitoring and evaluation/accountability framework.
Vaccine
; 38(33): 5379-5383, 2020 07 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-32430149
16.
Global Vaccine Action Plan Lessons Learned II: Stakeholder Perspectives.
Vaccine
; 38(33): 5372-5378, 2020 07 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-32505440
17.
The potential impact of human visceral leishmaniasis vaccines on population incidence.
PLoS Negl Trop Dis
; 14(7): e0008468, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32614857
18.
Bacillus Calmette-Guérin (BCG) vaccine: A global assessment of demand and supply balance.
Vaccine
; 36(4): 498-506, 2018 01 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-29254839